Cargando…
In vivo anti‐V‐ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses
Tumor acidity is the key metabolic feature promoting cancer progression and is modulated by pH regulators on a cancer cell's surface that pump out excess protons/lactic acid for cancer cell survival. Neutralizing tumor acidity improves the therapeutic efficacy of current treatments including im...
Autores principales: | Kulshrestha, Arpita, Katara, Gajendra K., Ibrahim, Safaa A., Riehl, Valerie E., Schneiderman, Sylvia, Bilal, Mahmood, Young, Alexandria N., Levine, Shayna, Fleetwood, Sara, Dolan, James, Gilman‐Sachs, Alice, Beaman, Kenneth D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530789/ https://www.ncbi.nlm.nih.gov/pubmed/32797726 http://dx.doi.org/10.1002/1878-0261.12782 |
Ejemplares similares
-
Cancer‐associated V‐ATPase induces delayed apoptosis of protumorigenic neutrophils
por: Ibrahim, Safaa A., et al.
Publicado: (2020) -
Interleukin‐22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer
por: Katara, Gajendra K., et al.
Publicado: (2019) -
Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells
por: Sahoo, Manoranjan, et al.
Publicado: (2018) -
Vacuolar ATPase ‘a2’ isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancer
por: Kulshrestha, Arpita, et al.
Publicado: (2015) -
Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H(+))-ATPase Inhibitors †
por: Patil, Renukadevi, et al.
Publicado: (2017)